These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 153845)

  • 41. Mutant genes that extend life span.
    Johnson TE; Friedman DB; Fitzpatrick PA; Conley WL
    Basic Life Sci; 1987; 42():91-100. PubMed ID: 3435398
    [No Abstract]   [Full Text] [Related]  

  • 42. A specific increase in chloroplast gene mutations following growth of Chlamydomonas in 5-fluorodeoxyuridine.
    Wurtz EA; Sears BB; Rabert DK; Shepherd HS; Gillham NW; Boynton JE
    Mol Gen Genet; 1979 Mar; 170(3):235-42. PubMed ID: 156870
    [No Abstract]   [Full Text] [Related]  

  • 43. Distribution of DNA or DNA synthesis in mammalian cells following inhibition with hydroxyurea and 5-fluorodeoxyuridine.
    Ockey CH; Allen TD
    Exp Cell Res; 1975 Jul; 93(2):275-82. PubMed ID: 125652
    [No Abstract]   [Full Text] [Related]  

  • 44. Fluorodeoxyuridine mediated cell cycle synchronization in S-phase increases the Auger radiation cell killing with 125I-iododeoxyuridine.
    Perillo-Adamer F; Kosinski M; Dupertuis YM; Viertl D; Bischof Delaloye A; Buchegger F
    Nuklearmedizin; 2009; 48(6):233-42. PubMed ID: 19795077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proceedings: Effects of hydroxyurea and 5-fluorodeoxyuridine on excision repair in human cells.
    Erixon K; Johansson B; Ahnström G
    Br J Cancer; 1975 Dec; 32(6):759. PubMed ID: 130155
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of 5-fluorodeoxyuridine on radiation-induced chromatid aberrations in Tradescantia microspores.
    Rushton PS
    Radiat Res; 1969 May; 38(2):404-13. PubMed ID: 4239043
    [No Abstract]   [Full Text] [Related]  

  • 47. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lifespan shortening of the nematode Caenorhabditis elegans under higher concentrations of oxygen.
    Honda S; Matsuo M
    Mech Ageing Dev; 1992 May; 63(3):235-46. PubMed ID: 1614224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effect of 5-fluorodeoxyuridine on the repair of gamma-ray-induced lesions in barley chromosomes.
    Yamamoto K; Yamaguchi H
    Mutat Res; 1969; 8(2):424-7. PubMed ID: 4243814
    [No Abstract]   [Full Text] [Related]  

  • 50. Toxoplasma gondii: the enzymic defect of a mutant resistant to 5-fluorodeoxyuridine.
    Pfefferkorn ER
    Exp Parasitol; 1978 Feb; 44(1):26-35. PubMed ID: 146608
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging.
    Johnson TE
    Science; 1990 Aug; 249(4971):908-12. PubMed ID: 2392681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects.
    Lucanic M; Plummer WT; Chen E; Harke J; Foulger AC; Onken B; Coleman-Hulbert AL; Dumas KJ; Guo S; Johnson E; Bhaumik D; Xue J; Crist AB; Presley MP; Harinath G; Sedore CA; Chamoli M; Kamat S; Chen MK; Angeli S; Chang C; Willis JH; Edgar D; Royal MA; Chao EA; Patel S; Garrett T; Ibanez-Ventoso C; Hope J; Kish JL; Guo M; Lithgow GJ; Driscoll M; Phillips PC
    Nat Commun; 2017 Feb; 8():14256. PubMed ID: 28220799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low survivorship of dauer larva in the nematode Caenorhabditis japonica, a potential comparative system for a model organism, C. elegans.
    Tanaka R; Okumura E; Kanzaki N; Yoshiga T
    Exp Gerontol; 2012 May; 47(5):388-93. PubMed ID: 22426108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lethal effects of fluorodeoxyuridine on cultured mammalian cells at various stages of the cell cycle.
    Lozzio CB
    J Cell Physiol; 1969 Aug; 74(1):57-62. PubMed ID: 4240541
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of 5-fluorodeoxyuridine on cell viability and uptake of deoxycytidine and (3H)cytosine arabinoside in L5178Y cells.
    Chu MY; Hoovis ML; Fischer GA
    Biochem Pharmacol; 1976 Feb; 25(3):355-7. PubMed ID: 131557
    [No Abstract]   [Full Text] [Related]  

  • 56. Toxoplasma gondii: characterization of a mutant resistant to 5-fluorodeoxyuridine.
    Pfefferkorn ER; Pfefferkorn LC
    Exp Parasitol; 1977 Jun; 42(1):44-55. PubMed ID: 140809
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro and in vivo effects of a non-toxic fluorodeoxyuridine-albumin conjugate.
    Fiume L; Derenzini M; Mattioli A; Busi C; Barbanti-Brodano G; Grossi MP; Bagnara GP; Brunelli MA
    Arch Sci Biol (Bologna); 1974; 58(1-4):95-100. PubMed ID: 4283492
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetic analysis of dauer formation in Caenorhabditis briggsae.
    Inoue T; Ailion M; Poon S; Kim HK; Thomas JH; Sternberg PW
    Genetics; 2007 Oct; 177(2):809-18. PubMed ID: 17660533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The sterilizing effect of pour-on flumethrin on the camel tick, Hyalomma dromedarii (Acari: Ixodidae).
    El-Azazy OM; Lucas SF
    Vet Parasitol; 1996 Feb; 61(3-4):339-43. PubMed ID: 8720571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticonvulsant medications extend worm life-span.
    Evason K; Huang C; Yamben I; Covey DF; Kornfeld K
    Science; 2005 Jan; 307(5707):258-62. PubMed ID: 15653505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.